PMO Interview with the Innovator Series: Volume 6
Lawrence M. Weiss, MD
Video Categories: PMO Interview with the Innovator Series
Alexander Bastian says the most important thing to come out of ASH that will improve standard of care is the variety of treatments coming available, including a new drug from Amgen for treating ALL.
Dixie-Lee Esseltine, MD and George Mulligan, PhD explain ixazomib’s mechanism of action and how the drug may fit into the treatment regimen for patients upon approval and beyond.